1998
DOI: 10.1002/(sici)1099-1077(1998100)13:7<525::aid-hup20>3.0.co;2-6
|View full text |Cite
|
Sign up to set email alerts
|

Serotonin syndrome following SSRI mono-therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2000
2000
2007
2007

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…5 The probability of serotonin syndrome increases significantly when SSRIs are used in combination with a monoamine oxidase inhibitor, but this syndrome has also been reported when SSRIs are used alone or administered with other serotonergtic agents such as lithium, buspirone, tramadol, or dextromethorphan. 5,6 Overdose situations in which SSRIs are combined with other serotonergic agents, therefore, have the potential for serious toxicity.…”
mentioning
confidence: 99%
“…5 The probability of serotonin syndrome increases significantly when SSRIs are used in combination with a monoamine oxidase inhibitor, but this syndrome has also been reported when SSRIs are used alone or administered with other serotonergtic agents such as lithium, buspirone, tramadol, or dextromethorphan. 5,6 Overdose situations in which SSRIs are combined with other serotonergic agents, therefore, have the potential for serious toxicity.…”
mentioning
confidence: 99%